The aim of this study was to evaluate the effect of immunization against gonadotropinreleasing factor (GnRF) with Bopriva ® (Pfizer Animal Health, Parkville, Australia) in prepubertal bull calves. For the study, 6 calves were vaccinated at the age of 3 and 6 weeks with 1 mL Bopriva ® , and 6 animals served as matched controls. Concentrations of GnRF antibodies, testosterone and LH were determined in serum samples out to 30 weeks after the first immunization. Body weight and scrotal circumference were measured for 59 weeks. At slaughter, 65 weeks after the first immunization, the quality of epididymal sperm was evaluated. The results showed that vaccination against GnRF influenced (P < 0.05) anti-GnRF titer, LH and testosterone concentrations as well as scrotal circumference. Antibody titers significantly (P < 0.05) increased after the booster vaccination and reached peak values 2 weeks later. Compared to control animals, inhibition (P < 0.05) of the prepubertal LH 2 secretion was observed in vaccinated calves at weeks 10 and 12 to 14 after the first vaccination. In vaccinated calves testosterone concentrations decreased after the booster injection to values below 0.5 ng/mL serum and remained for at least 22 weeks at this low level. Animals vaccinated with Bopriva ® showed a delay in testes growth and smaller scrotal circumference. Puberty occurred at the age between 46 and 55 weeks in vaccinated and between 38 and 52 weeks in control animals and body weight gain was similar in both groups.
Introduction
Immunological methods represent animal-friendly alternatives to physical castration in animals. Immunization against sex hormones, LH receptors, sperm antigens or zona pellucida proteins has been described (Fayrer-Hosken, 2008) . In the male as in the female, GnRF (gonadotropin-releasing factor) plays a central role in the regulation of sexual function. After immunization against GnRF, antibodies neutralize the endogenous GnRF resulting in the suppression of secretion of the gonadotropins LH and FSH in the anterior pituitary. The effectiveness of vaccination against GnRF could be demonstrated in numerous studies in cattle (Aissat et al., 2002; Cook et al., 2000; D'Occhio et al., 2001; Finnerty et al., 1998; Geary et al., 2006; Hoskinson et al., 1990; Jago et al., 1997; Jeffcoate et al., 1982; Neeson and Colson, 2004; Stevens et al., 2005; Theubet et al., 2010) , sheep (Brown et al., 1994 (Brown et al., , 1995 Ferro et al., 2004; Janett et al., 2003 Janett et al., , 2009a Jeffcoate et al., 1982; Ülker et al., 2005) , pig (Bonneau et al., 1994; Clarke et al., 2008; Claus et al., 2007; Dunshea et al., 2001; Fuchs et al., 2009; Jaros et al., 2005; Zamaratskaia et al., 2008) , horse (Dalin et al., 2002; Elhay et al., 2007; Imboden et al., 2006; Janett et al., 2009b; Schanbacher and Pratt, 1985; Turkstra et al., 2005) and in wild animals (Curtis et al., 2002; Miller et al., 2000 Miller et al., , 2004 .
Regarding reversibility of immunization against GnRF, it has been known that the effects on fertility are individual and may last for a prolonged time (Brown et al., 1994 (Brown et al., , 1995 Clarke et al., 1998; Janett et al., 2003) . Ram lambs immunized twice at an age of 3 to 4 weeks and 13 to 14 weeks against GnRF showed a decreased testicular size when they reached 2 years of age (Brown et al., 1994) . In another study (Janett et al., 2003) one out of 10 peripubertal vaccinated ram lambs had low testicular size and blood testosterone concentrations for more than 1 year after the booster vaccination. Also in pre-and peripubertal immunized female lambs, 60% displayed no estrus and small uteri as well as ovaries at 2 years of age (Brown et al., 1995) . These studies clearly demonstrate that inhibition of GnRF secretion in juvenile animals can hamper fertility in adulthood. In bull calves, blood concentrations of gonadotropins increase long before the animal reaches puberty. It has been shown that LH starts to rise from 6 weeks of age reaching peak values between 12 to 16 weeks and subsequently drops to basal concentrations at week 25 of life remaining low until attainment of puberty (Amann and Walker, 1983; Aravindakshan et al., 2000; Bagu et al., 2006; Evans et al., 1996; Lacroix and Pelletier, 1979; McCarthy et al., 1979; Rawlings and Evans, 1995; Rawlings et al., 1978 Rawlings et al., , 2008 Rodriguez and Wise, 1989) . The early rise in gonadotropin secretion seems to be essential for normal testicular development and reproductive maturation in bull calves Rawlings et al., 2008) . Inhibition of GnRF secretion by 4 application of a long-acting GnRF agonist in 6 to 18 week old calves has been shown to led to a marked delay in testicular development (Chandolia et al., 1997) . Similarly sustained inhibition of GnRF secretion by vaccination against GnRF early in life may also suppress the prepubertal rise in GnRF and offer a true alternative to castration in bull calves. Results from a pilot project (Theubet et al., 2010) 
Material and methods

Experimental design
For the experiments 12 Holstein Friesian bull calves, all born within a week of each other, were purchased in the first week of life from 9 different farms. For the first 14 weeks of age they were fed skim powder-based milk replacer with free access to water, hay, straw and minerals. Until 8 months of age (period 1), the animals were housed together in a group corral on straw with regular access to pasture. From the age of 8 months until slaughter at 15 months (period 2) the bulls were kept in a pen on straw and a high-energy finishing diet was provided.
At the beginning of the experiment 6 animals were randomly allocated to a treatment group (A-F) and 6 calves served as controls (G-L). At the age of 3 and 6 weeks the animals of the treatment group were vaccinated subcutaneously with 1 mL Bopriva 
Hormone analysis and GnRF antibody titers
GnRF antibody titers
Serum anti-GnRF antibody titers were determined by dissociation enhanced lanthanide fluorescence immunoassay (DELFIA) (Perkin Elmer Pty Ltd, Glen Waverly, Australia).
Briefly, 384-well streptavidin coated plates (Perkin Elmer Pty Ltd, Glen Waverly, Australia)
were coated for 1 h at room temperature with 1 µg/mL biotinylated GnRF peptide in DELFIA buffer (50mM Tris-HCl, 0.9 % NaCl, 0.05 % Tween 20, 20 µM EDTA, 0.2 % ovalbumin).
Plates were washed and then incubated with serial dilutions of test cattle serum for 1 h at room temperature. Unbound serum and antibodies were removed by washing, and bound antibody was detected by incubating plates for a further 1 h with europium labeled protein G (Perkin Elmer Pty Ltd, Glen Waverly, Australia). After washing off excess europium labeled 6 protein G, DELFIA Enhancement Solution (Perkin Elmer Pty Ltd, Glen Waverly, Australia) was added to all wells. After 10 min plates were excited at 340 nm and emission readings at 615 nm were measured. Serial dilutions of a standard with a reciprocal titer of 1/409,600 served as a reference for unknown samples. Reciprocal titer was determined as the highest serum dilution at which the 615 nm fluorescence was two standard deviations higher than the negative control. Non-vaccinated cattle serum served as a negative control.
Testosterone concentrations
Testosterone was determined by enzyme-amplified sensitivity immunoassay (TESTO-EASIA, BioSource Europe S.A, Nivelles, Belgium). The detection limit of the assay was 0.01 ng/mL.
All samples were analyzed using a competitive binding assay where a fixed amount of testosterone labeled with horseradish peroxidase (HRP) competes with unlabelled testosterone present in calibrators, controls and samples. Cross reactivity with estrogens and progesterone was 0.023 % and 0.035 %, respectively, with androstenedione 0.76 % and 5-α-dihydrotestosterone 0.61 %. The intra-and inter-assay coefficients of variance were 6.3 % and 8.3 %, respectively.
LH concentrations
LH measurements were performed using enzyme-linked immunosorbent assay (ELISA) (LH-DETECT ® , ReproPharm, Nouzilly, France) with a sensitivity of 0.01 ng LH/mL. The intraand inter-assay coefficients of variance were 5.9 % and 8.4 %, respectively.
Testicular weight and sperm quality
From the testes recovered after slaughter, the cauda epididymis including the proximal vas deferens was separated from each testis and paired testes weight determined. For the collection of epididymal sperm the ductus deferens and the cauda epididymis were flushed in a retrograde direction with 10 mL bull semen extender (AndroMed  , Minitüb GmbH, Tiefenbach, Germany). Harvested semen from both caudae epididymidae of each bull was extended and total sperm count as well as sperm motility were determined with a sperm analyzer (CASA) (Hamilton Thorne IVOS, Version 14, Beverly, MA, USA) using standardized settings for bull semen (Table 1) and abnormal spermatozoa classified in major (acrosome defects, nuclear vacuoles, abnormal heads, loose abnormal heads, abnormal midpieces, proximal droplets) and minor (loose normal heads, abnormal tails, distal droplets) defects (Blom, 1973) . 
Statistical analysis
The data were analyzed using R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria) version 2.14.0 and the software package nlme (Pinheiro et al., 2011 (Lunstra et al., 1978; Wolf et al., 1965) . Pairwise comparisons were performed after Bonferroni adjustment in parametric and Mann-Whitney test in nonparametric distributed data, respectively. Values were considered to be statistical significant at P < 0.05.
Results
Adverse effects
All calves treated with Bopriva ® showed no signs of apathy but 1-2 days after the first and second immunization, an individual rise in body temperature to peak values of 40.7 °C was observed. A slight non-painful swelling at the injection site developed in all vaccinated animals and spontaneously subsided within 2-4 weeks. In control animals, body temperature varied between 37.9 °C and 40.1 °C and no adverse effects could be seen.
Effects of vaccination
Effects of group, time of examination and interaction of group and time of examination on evaluated parameters are shown in Table 2 . It is apparent that the time of examination significantly (P < 0.05) influenced all parameters. The group and the interaction of group and time of examination significantly influenced all parameters with exception of body weight. Table 2 Effects of group, time of examination and interaction of group and time on evaluated parameters.
Parameter Group Testosterone Mean (± SEM) serum testosterone concentrations in bull calves with and without Bopriva  were followed for 30 weeks after first immunization as shown in Fig. 1c . In vaccinated animals the values were always < 0.5 ng/mL during weeks 0-24 and continuously increased thereafter. Testosterone concentrations in control animals were > 0.5 ng/mL except at weeks 0-2, 4 and 15. Significant differences between groups were noted for weeks 5-12, 14-17, 21 and 25. were not significant (P > 0.05).
Age at puberty, testicular weight and semen quality
Vaccinated calves attained puberty at the age between 46 and 55 weeks (median 50 weeks) and in control animals between 38 and 52 weeks of age (median 47 weeks) as shown in Fig.   3a .
Testicular weight was determined at slaughter at week 65, when the bulls were 68 weeks old as shown in Fig. 3b . Paired testes weight ranged between 481 g and 634 g (median 573 g) in vaccinated and between 508 g and 831 g (median 666 g) in control animals. ) in control bulls (Fig. 3c ).
Sperm motility ranged between 26 % and 68 % (median 43 %) in vaccinated and between 12 % and 77 % (median 54 %) in control animals (Fig. 3d) . The percentage of sperm with major ( Fig. 3e ) and specifically acrosome (Fig. 3f ) defects ranged between 16 % and 72 % (median 29 %) and between 2 % and 7 % (median 4 %) in vaccinated animals, respectively. In control animals major sperm defects ranged between 12 % and 93 % (median 59 %) and acrosome defects between 1 % and 9% (median 5 %), respectively. No significant (P > 0.05) differences in age at puberty, testicular weight and semen characteristics were apparent between groups.
Discussion
Results of this study show that compared to control animals vaccination of bull calves with Bopriva ® at an age of 3 and 6 weeks suppressed testicular development and endocrine function for more than 22 weeks. General health, suckling and weight gain were not affected by immunization against GnRF. Also, semen quality evaluated at the end of the experiment was similar in bulls with and without Bopriva ® . However, a temporary increase in body temperature and a slightly transient swelling at the injection site was observed in all vaccinated animals. The high degree of safety of Bopriva ® is mainly due to the fact that the vaccine was developed specifically for cattle and that the adjuvant used is well tolerated in the bovine species.
After the first immunization, all calves showed a low anti-GnRF antibody titer which rapidly increased following the booster injection. This confirms the findings of Chase et al. (2008) , that 3 to 6 weeks old calves are able to produce a reliable immune response. Titers determined in this study were even higher and more sustained than those measured in a previous 16 investigation using Bopriva ® in pubertal bulls (Theubet et al., 2010) . One explanation for the inconsistent titer reaction could be a more efficient antigen presentation in the lymph nodes as in the present study both immunizations were applied on the same site of the neck and not on opposite sites (Theubet et al., 2010) . Control animals showed a continuous increase of LH to levels of 0.3 ng/mL serum. These values are much lower than concentrations of about 1.6 ng/mL reported in previous studies (Evans et al., 1993; Bagu et al., 2006) , the reason being most likely due the method of LH analysis used, breed differences and most important the frequency of blood sampling. In the experiments mentioned above blood was collected at short intervals of 10-12 min during several hours and the basal, amplitude and mean concentrations of LH determined. This approach allows detecting increases in LH pulse frequency which is mainly responsible for the prepubertal gonadotropin rise (Evans et al., 1993) reported in previous studies (Aravindakshan et al., 2000; Bagu et al., 2006; Chandolia et al., 1997; Evans et al., 1993) . A possible cause for the different findings may be breed influence, as our experiment was performed with Holstein calves whereas Hereford (Chandolia et al., 1997; Evans et al., 1993) or crossbreeds of Hereford and Charolais (Aravindakshan et al., 2000; Bagu et al., 2006) were used in the previous studies. Moreover, it has been known that diet and weight gain may also influence LH secretion and the attainment of puberty (Barth et al., 2008; Brito et al., 2007a Brito et al., , 2007b .
Testosterone secretion was suppressed concomitant with the rise of anti-GnRF titers after booster vaccination. The duration of testosterone inhibition lasted for at least 22 weeks and concentrations started to increase individually when titers reached baseline values.
Surprisingly, a delay of 6 weeks between the resumptions of LH and testosterone secretion was observed. The persistently low testosterone values despite increased LH concentrations suggest that the immunization effect is not solely based on the neutralization of GnRF but also a weaker responsiveness of testicular receptors to gonadotropins. It might be possible that vaccination leads to delayed formation of LH receptors on Leydig cells as also assumed by elevated testicular temperatures in short scrotum bulls (Thun et al., 1980) . In calves with Bopriva ® a marked delay in testicular development was obvious and at slaughter when animals were 68 weeks old paired testes weight tended to be lower in vaccinated compared to control animals. These observations are consistent with studies in the lamb (Brown et al., 1994 (Brown et al., , 1995 Clarke et al., 1998; Janett et al., 2003) where it has been shown that vaccination against GnRF in juvenile animals can lead to incomplete development of the genital tract. In this experiment the vaccinated bulls had a total sperm count of more than 3 x 10 9 and a sperm motility between 26 to 68 % in semen harvested from the epididymides after slaughter. These values were similar to those found in control animals indicating that the vaccinated bulls had attained spermatogenic capacity and might be judged as fertile.
Body weight gain was not influenced by immunization against GnRF which agrees with previous studies in cattle (Aissat et al., 2002; Cook et al., 2000; D'Occhio et al., 2001; Neeson and Colson, 2004) and in sheep (Brown et al., 1994; Janett et al., 2003) .
Conclusions
This study demonstrates that immunization against GnRF with Bopriva ® in bull calves at 3 and 6 weeks of age significantly inhibited the prepubertal LH rise. Furthermore, vaccination led to a suppression of testosterone secretion for more than 22 weeks and a delay in testicular development.
